ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Multiscale dynamics of COVID-19 and model-based recommendations for 105 countries
This article has 3 authors:Reviewed by ScreenIT
-
Impact of Governmental interventions on epidemic progression and workplace activity during the COVID-19 outbreak
This article has 2 authors:Reviewed by ScreenIT
-
The effect of strict lock down measures on Covid-19 seroprevalence rate and herd immunity
This article has 6 authors:Reviewed by ScreenIT
-
Altered Heart Rate Variability Early in ICU Admission Differentiates Critically Ill Coronavirus Disease 2019 and All-Cause Sepsis Patients
This article has 6 authors:Reviewed by ScreenIT
-
‘Drawing on Wisdom to Cope with Adversity:’ A Systematic Review Protocol of Older Adults’ Mental and Psychosocial Health During Acute Respiratory Disease Propagated-Type Epidemics and Pandemics (COVID-19, SARS-CoV, MERS, and Influenza)
This article has 6 authors:Reviewed by ScreenIT
-
The Era of Coronavirus: Knowledge, Attitude, Practices, and Barriers to Hand Hygiene Among Makerere University Students and Katanga Community Residents
This article has 6 authors:Reviewed by ScreenIT
-
First environmental surveillance for the presence of SARS-CoV-2 RNA in wastewater and river water in Japan
This article has 4 authors:Reviewed by ScreenIT
-
Protein covariance networks reveal interactions important to the emergence of SARS coronaviruses as human pathogens
This article has 2 authors:Reviewed by ScreenIT
-
Synthetic antibodies neutralize SARS-CoV-2 infection of mammalian cells
This article has 17 authors:Reviewed by ScreenIT
-
Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States
This article has 16 authors:Reviewed by ScreenIT